Meta-analysis: Magnesium critical partner to calcium supplementation
ORANGE, Calif. — Without magnesium, calcium supplements increase risk of heart attacks, according to a meta-analysis recently conducted by Carolyn Dean, medical director of the Nutritional Magnesium Association.
"If we consume too much calcium without sufficient magnesium, the excess calcium is not utilized correctly and may actually become toxic, causing painful conditions, such as some forms of arthritis, kidney stones, osteoporosis and calcification of the arteries leading to heart attack and cardiovascular disease," Dean said.
There needs to be about a 2:1 ration of magnesium to calcium in order for calcium to be effectively absorbed into the body, Dean claimed, making magnesium supplementation more important than calcium in order to maintain both healthy bones and healthy hearts.
The meta-analysis, published in the British Medical Journal, was based on the results of five clinical trials conducted in the United States, Great Britain and New Zealand that involved more than 8,000 people.
Lilly invests in partnership to fight NCDs
INDIANAPOLIS — Drug maker Eli Lilly is investing $30 million in a partnership that will address noncommunicable diseases, also known as chronic diseases.
The Lilly NCD Partnership is committed to fight the rising burden of noncommunicable diseases in developing nations over the next five years, the drug maker said. The first phase of the partnership will focus on improving diabetes care in targeted communities in Brazil, India, Mexico and South Africa.
Chronic diseases disproportionately affect the economically disadvantaged, with 80% of all NCD deaths occurring in low- and middle-income countries, Lilly said.
"Noncommunicable diseases are afflicting nations, communities and families around the world, with the most vulnerable bearing most of the burden," Lilly chairman, president and CEO John Lechleiter said. "We believe we have a responsibility — and are uniquely positioned — to assist in the global fight against these diseases. In partnership with leading health organizations, Lilly will contribute its deep expertise and the company’s broad research capabilities to help find solutions for these pressing societal needs."
The Lilly NCD Partnership, the drug maker said, complement the Lilly MDR-TB Partnership, a program the company launched in 2003 to help address multidrug resistant tuberculosis.
Duracell teams up with wireless charger company Powermat
BETHEL, Conn., and NEW YORK — Procter & Gamble’s Duracell brand announced a joint venture with wireless charger company Powermat.
As part of the strategic alliance between Duracell and Powermat, the companies will deliver best-in-class wireless power solutions. Additionally, P&G also expects to make an equity investment in Powermat.
The joint venture is expected to commence next year, the companies said.
"Several decades ago, Duracell was a pioneer in a new revolutionary product category, alkaline roundcell batteries," Duracell president Stassi Anastassov said. "Today, it is a multibillion dollar category. In a not too distant future, we expect wireless power solutions to eliminate the hassle of multiple cords and chargers, creating a major growth opportunity. Innovation to create new solutions that touch and improve people’s lives is what P&G-Duracell are all about. The JV between Duracell and Powermat puts us in the driver-seat for this disruptive category creation."